{
  "drug_name": "Sarecycline",
  "tradename": "Seysara",
  "usage_and_dosing": {
    "indicated_for": "treatment of the inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in patients age ≥9 years.",
    "efficacy_and_safety_notes": [
      "Efficacy beyond 12 weeks and safety beyond 12 months are not established.",
      "Avoid using in males attempting to conceive a child (adverse effects in an animal fertility study).",
      "Take each dose with adequate fluid to reduce risk of esophageal irritation or ulceration.",
      "Not evaluated in the treatment of infections."
    ],
    "adult_dose": [
      {
        "body_weight_kg": "33-54",
        "dose": "60 mg po q24h"
      },
      {
        "body_weight_kg": "55-84",
        "dose": "100 mg po q24h"
      },
      {
        "body_weight_kg": "85-136",
        "dose": "150 mg po q24h"
      }
    ],
    "pediatric_dose": {
      "age_gt_9_yrs": [
        {
          "weight_kg": "33-54",
          "dose": "60 mg po q24h"
        },
        {
          "weight_kg": "55-84",
          "dose": "100 mg po q24h"
        },
        {
          "weight_kg": "85-136",
          "dose": "150 mg po q24h"
        }
      ]
    }
  },
  "renal_adjustment": {
    "body_weight_and_creatinine_clearance_calculations": true,
    "half_life_normal": "21-22",
    "half_life_esrd": "No data",
    "dose_renal_function_normal": "60-150 mg po q24h",
    "crcl_or_egfr": "No dosage adjustment for renal impairment (not studied in ESRD)",
    "hemodialysis": "No data",
    "capd": "No data",
    "crrt": "No data",
    "sled": "No data"
  },
  "hepatic_adjustment": {
    "mild_impairment": "No dosage adjustment",
    "moderate_impairment": "No dosage adjustment",
    "severe_impairment": "No data"
  },
  "adverse_effects": {
    "adverse_effects": [
      "GI (most common adverse effect is nausea, incidence ≥1%).",
      "Esophageal irritation or erosion if inadequate fluid taken with each dose. Risk of esophageal adverse effects possibly higher than with other tetracyclines (J Am Acad Dermatol 2022;87:1150).",
      "CNS (lightheadedness, dizziness, vertigo, pseudotumor cerebri).",
      "Intracranial hypertension.",
      "Photosensitivity, possibly more likely than with other tetracyclines (J Am Acad Dermatol 2022;87:1150).",
      "C. difficile-associated diarrhea."
    ]
  },
  "pregnancy_risk": {
    "fda_risk_category": "Do not use (risk of fetal harm, tooth discoloration, inhibition of bone growth)",
    "lactation": "No data, avoid use"
  },
  "pharmacology": {
    "pk_pd_index": "24-hr AUC/MIC",
    "preparations": "Tab (60, 100, 150 mg)",
    "food_recs": "Tab + food",
    "oral_absorption": "No data",
    "tmax_hr": "1.5-2.0",
    "peak_serum_conc": "No data",
    "peak_urine_conc": "No data",
    "protein_binding": "62.5-74.7",
    "volume_of_distribution": "91.4-97.0 (Vss)",
    "avg_serum_t1_2": "21-22",
    "elimination": "Fecal, renal",
    "bile_penetration": "No data",
    "csf_blood": "No data",
    "therapeutic_levels_in_csf": "No data",
    "auc": "No data"
  },
  "enzyme_transporter_mediated_interactions": {
    "transporters_inhibited": [
      "PGP"
    ],
    "impact_on_serum_drug_concentrations": "↑"
  },
  "major_drug_interactions": [
    {
      "drug": "Antacids (Al, Ca, Mg)",
      "effect": "↓ sarecycline",
      "suggestion": "Separate dosing"
    },
    {
      "drug": "Bismuth subsalicylate",
      "effect": "↓ sarecycline",
      "suggestion": "Separate dosing"
    },
    {
      "drug": "Digoxin",
      "effect": "↑ digoxin (inhibition of P-glycoprotein)",
      "suggestion": "Monitor, adjust dosage"
    },
    {
      "drug": "Iron-containing preps",
      "effect": "↓ sarecycline",
      "suggestion": "Separate dosing"
    },
    {
      "drug": "Penicillin",
      "effect": "↓ penicillin bactericidal activity",
      "suggestion": "Avoid co-administration"
    },
    {
      "drug": "Retinoids",
      "effect": "↑ intracranial pressure (pseudotumor cerebri)",
      "suggestion": "Avoid co-administration"
    },
    {
      "drug": "Warfarin",
      "effect": "↑ INR",
      "suggestion": "Monitor INR, adjust dosage"
    }
  ],
  "comments": [
    "Review: Med Lett Drugs Ther 2019;61:43."
  ]
}